APA (7th ed.) Citation

A, C., N, A., RSP, R., K, R., X, Y., J, M., . . . PM, D. (2018). Overexpression of Tpl2 is linked to imatinib resistance and activation of MEK-ERK and NF-κB pathways in a model of chronic myeloid leukemia. Molecular oncology, 12(5), 630. https://doi.org/10.1002/1878-0261.12186

Chicago Style (17th ed.) Citation

A, Chorzalska, et al. "Overexpression of Tpl2 Is Linked to Imatinib Resistance and Activation of MEK-ERK and NF-κB Pathways in a Model of Chronic Myeloid Leukemia." Molecular Oncology 12, no. 5 (2018): 630. https://doi.org/10.1002/1878-0261.12186.

MLA (9th ed.) Citation

A, Chorzalska, et al. "Overexpression of Tpl2 Is Linked to Imatinib Resistance and Activation of MEK-ERK and NF-κB Pathways in a Model of Chronic Myeloid Leukemia." Molecular Oncology, vol. 12, no. 5, 2018, p. 630, https://doi.org/10.1002/1878-0261.12186.